Can you share a case of a pediatric patient with severe AD, in whom you intensified therapy with dupilumab, and what the outcome was? How did the discussion evolve with the family and what end points were affected after how many months of therapy?

Can you share a case of a pediatric patient with severe AD, in whom you intensified therapy with dupilumab, and what the outcome was? How did the discussion evolve with the family and what end points were affected after how many months of therapy?

CLICK HERE FOR CME CREDIT Back to Symposium

Can you share a case of a pediatric patient with severe AD, in whom you intensified therapy with dupilumab, and what the outcome was? How did the discussion evolve with the family and what end points were affected after how many months of therapy?

Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Lawrence Eichenfield, MD

Lawrence Eichenfield, MD

Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital-San Diego
Vice Chair, Department of Dermatology
Professor of Dermatology and Pediatrics
UC San Diego School of Medicine